Cargando…
Myeloid expression of the anti-apoptotic protein Mcl1 is required in anti-myeloperoxidase vasculitis but myeloperoxidase inhibition is not protective
Antibodies to neutrophil and monocyte myeloperoxidase and proteinase 3 are a feature of anti-neutrophil cytoplasmic antibody vasculitis, a disease with significant morbidity for which new treatments are needed. Mice with a myeloid-specific deletion of the anti-apoptotic protein Mcl1 have reduced num...
Autores principales: | Florez-Barros, Fernanda, Bearder, Siobhan, Kull, Bengt, Freeman, Adrian, Mócsai, Attila, Robson, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166712/ https://www.ncbi.nlm.nih.gov/pubmed/36154801 http://dx.doi.org/10.1016/j.kint.2022.08.028 |
Ejemplares similares
-
Experimentally Induced Anti-Myeloperoxidase Vasculitis Is Not Attenuated in Factor B or VISTA Deficient Mice
por: Flórez-Barrós, Fernanda, et al.
Publicado: (2021) -
Pulmonary fibrosis—an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
por: Bhanji, Amir, et al.
Publicado: (2010) -
Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis
por: Gou, Shen-Ju, et al.
Publicado: (2013) -
Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases
por: Odobasic, Dragana, et al.
Publicado: (2021) -
Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)